You can get access to information on Huons and its development of new products

• 38
  Huons N Participates in Vitafoods Europe 2026... Expanding Global Partnerships PR · 2026.05.07
• 37
  Huons N to Absorb Wholly Owned Subsidiary BioRosette Through Merger PR · 2026.04.30
• 36
  Huons Announces the Company Absorption Merger with its Wholly-owned Subsidiary HuonsLifeSciences 휴온스 · 2026.04.22
• 35
  PanGen Biotech Expands Cell-Based Bioassay Services to Strengthen Competitiveness 휴온스 · 2026.04.01
• 34
  Huons Signs Distribution and Co-promotion Agreement with Sanofi Korea for 5 Vaccines, Entering Vaccine Business 휴온스 · 2026.03.25
• 33
  Huons Gains IND Approval for Phase 2 Clinical Trial of New Drug for Dry Eye Syndrome 휴온스 · 2026.03.12
• 32
  PanGen Biotech Announces FY2025 Results, Revenue of KRW 13.42 Billion, Operating Profit at 1.51 Billion 휴온스 · 2026.02.03
• 31
  Huons Signs Distribution Agreement with Rappeler for Vitamin C and G6PD Diagnostic Devices 휴온스 · 2026.01.30
• 30
  Huons Gains IND Approval to initiate Phase 1 Clinical Trial of Anti-obesity Treatment ‘HUC2-676’ in Korea 휴온스 · 2025.12.17
• 29
  Three Affiliates of Huons Group Honored with Export Tower Awards on Trade Day 휴온스 · 2025.12.08

All Title Content Writer